|Articles|July 1, 2015
Addressing Pharma Industry Issues
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) speaks with Biopharm International.
Advertisement
Richard Johnson, President and CEO of the Parenteral Drug Association (PDA) spoke with BioPharm International about drug shortages, manufacturing challenges, and industry issues.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Next-Generation Modalities Drive New Antibody Discovery
2
New $82 Million Biopharma Launch Targets Rare Disease Development With AI-Driven Strategy
3
European Approval of Donidalorsen Expands RNA-Targeted Prevention Strategies for HAE
4
GSK Acquisition of RAPT Signals Shift Toward Long-Acting Anti-IgE Therapies
5